These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1724038)

  • 1. [Antibody-dependent cytotoxic method of determining the number of natural killer cells in the peripheral blood].
    Pastushenkov VL; Mitin IuA; Kuz'mich AN
    Lab Delo; 1991; (7):48-9. PubMed ID: 1724038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cells.
    Perussia B; Loza MJ
    Methods Mol Biol; 2000; 121():179-92. PubMed ID: 10818726
    [No Abstract]   [Full Text] [Related]  

  • 4. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
    Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
    Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
    Metha BA; Advani SH; Nadkarni SJ
    Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
    Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
    Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.
    Titus JA; Perez P; Kaubisch A; Garrido MA; Segal DM
    J Immunol; 1987 Nov; 139(9):3153-8. PubMed ID: 2959724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
    Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
    Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxic effect of peripheral blood lymphocytes in ulcerative colitis].
    Tomecki R
    Pol Tyg Lek; 1980 Aug; 35(34):1315-6. PubMed ID: 7443561
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia.
    Gupta S; Fernandes G
    J Clin Lab Immunol; 1983 Nov; 12(3):155-7. PubMed ID: 6607357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human IgG1 and mouse IgG3 but not monomeric IgM or IgE facilitate antibody-dependent cell-mediated cytotoxicity by human natural killer cells.
    Shenoy AM; Brahmi Z
    Nat Immun Cell Growth Regul; 1989; 8(6):338-48. PubMed ID: 2622463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of immunological parameters during tumour development in a murine model.
    Suresh K; Nirmala K; Kuruvilla K; Vasudevan DM
    Indian J Exp Biol; 1989 Jun; 27(6):497-501. PubMed ID: 2583740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of natural killer cells (NK cells) and features of the cytotoxic test in Syrian hamsters].
    Kliuchareva TE; Matveeva VA
    Biull Eksp Biol Med; 1983 Oct; 96(10):86-8. PubMed ID: 6626738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.
    Voltarelli JC; Gjerset G; Anasetti C
    Immunology; 1993 Jul; 79(3):509-11. PubMed ID: 8104886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.